> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Cancer Experts Endorse Woodcock for Commissioner
- URL: https://www.fdaweb.com/cancer-experts-endorse-woodcock-for-commissioner/
- Published: 2021-02-11T12:00:00.000Z
- Updated: 2026-09-14T16:46:24.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148648

Some 94 oncology physicians, researchers, and leaders have signed a 2/11 letter to President **Joseph Biden** urging the selection of FDA acting commissioner **Janet Woodcock** to be the agency’s next commissioner. Those signing the [letter](https://www.washingtonpost.com/context/cancer-experts-endorse-acting-fda-commissioner/028d986e-9d51-4a81-a2b0-e7c1386557c4/?itid=lk%5Finline%5Fmanual%5F25.&ref=fdaweb.com) include some who served on Biden’s Cancer Moonshot Blue Ribbon Panel when he was vice president.

“As leaders in oncology with decades of experience, we know that now, more than ever, FDA requires a strong and respected leader who has the deep understanding of science, public health, and drug development to steer the country through these unprecedented challenges,” the letter says. “Taking the next step and nominating Woodcock as FDA commissioner is the leadership we need to move forward in our deep understanding of science and would affirm to the American public that FDA will continue to be the global gold standard to change patients’ lives for the better. Woodcock is uniquely qualified to run FDA at this vital moment for the science and research taking place across the country. Many of us have known Woodcock throughout her decades of service as the director of FDA’s Center for Drug Evaluation and Research. We have witnessed her impeccable ability to lead the agency as it maintains the highest global standard for regulatory science, innovation, and protecting public health.”

Recently, support for Woodcock was voiced in a *Los Angeles Times* [op-ed](https://www.fdaweb.com/la-times-op-ed-backs-woodcock-for-fda-head/), while Public Citizen and 28 other advocacy groups notified Biden that they [opposed](https://www.fdaweb.com/29-groups-oppose-woodcock-nomination-over-opioids/) her nomination.